You are here

Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.

TitleHumanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.
Publication TypeJournal Article
Year of Publication2010
AuthorsLibby, SJ, Brehm, MA, Greiner, DL, Shultz, LD, McClelland, M, Smith, KD, Cookson, BT, Karlinsey, JE, Kinkel, TL, Porwollik, S, Canals, R, Cummings, LA, Fang, FC
JournalProc Natl Acad Sci U S A
Volume107
Issue35
Pagination15589-94
Date Published2010 Aug 31
ISSN1091-6490
KeywordsAnimals, Animals, Newborn, Antigens, CD45, Cytokines, Female, Flow Cytometry, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells, Humans, Interferon-gamma, Interleukin Receptor Common gamma Subunit, Male, Mice, Mice, Inbred C57BL, Mice, Inbred NOD, Mice, Knockout, Mice, SCID, Salmonella typhi, Tumor Necrosis Factor-alpha, Typhoid Fever, Virulence
Abstract

Salmonella enterica serovar Typhi, the cause of typhoid fever, is host-adapted to humans and unable to cause disease in mice. Here, we show that S. Typhi can replicate in vivo in nonobese diabetic (NOD)-scid IL2rgamma(null) mice engrafted with human hematopoietic stem cells (hu-SRC-SCID mice) to cause a lethal infection with pathological and inflammatory cytokine responses resembling human typhoid. In contrast, S. Typhi does not exhibit net replication or cause illness in nonengrafted or immunocompetent control animals. Screening of transposon pools in hu-SRC-SCID mice revealed both known and previously unknown Salmonella virulence determinants, including Salmonella Pathogenicity Islands 1, 2, 3, 4, and 6. Our observations indicate that the presence of human immune cells allows the in vivo replication of S. Typhi in mice. The hu-SRC-SCID mouse provides an unprecedented opportunity to gain insights into S. Typhi pathogenesis and devise strategies for the prevention of typhoid fever.

DOI10.1073/pnas.1005566107
Alternate JournalProc. Natl. Acad. Sci. U.S.A.
PubMed ID20713716